Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer

The Effects of Vandetanib on Paclitaxel Tumor Distribution and Antitumor Activity in a Xenograft Model of Human Ovarian Carcinoma

(2015) Marta Cesca et al.   NEOPLASIA

Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials

(2013) F. Coccolini et al.   EJSO

Determination of Paclitaxel Distribution in Solid Tumors by Nano-Particle Assisted Laser Desorption Ionization Mass Spectrometry Imaging

(2013) Lavinia Morosi et al.   PLoS One

Peritoneal carcinomatosis

(2013) Federico Coccolini   WORLD JOURNAL OF GASTROENTEROLOGY

Cytoreductive Surgery with Selective Versus Complete Parietal Peritonectomy Followed by Hyperthermic Intraperitoneal Chemotherapy in Patients with Diffuse Malignant Peritoneal Mesothelioma: A Controlled Study

(2012) Dario Baratti et al.   ANNALS OF SURGICAL ONCOLOGY

Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis

(2012) P. H. Cashin et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Evaluation of Extensive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Epithelial Ovarian Cancer

(2012) Luca Ansaloni et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Pharmacology of Perioperative Intraperitoneal and Intravenous Chemotherapy in Patients with Peritoneal Surface Malignancy

(2012) Kurt Van der Speeten et al.   Surgical Oncology Clinics of North America

Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case-control study

(2011) P. H. Cashin et al.   ANNALS OF ONCOLOGY

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

(2011) Xiao-Jun Yang et al.   ANNALS OF SURGICAL ONCOLOGY

In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™)

(2011) A. Canta et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents

(2011) S. Uboldi et al.   INTERNATIONAL JOURNAL OF CANCER

Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome

(2011) Terence C. Chua et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Spatial distribution of intraperitoneally administrated paclitaxel nanoparticles solubilized with poly (2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) in peritoneal metastatic nodules

(2010) Takao Kamei et al.   CANCER SCIENCE

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer

(2009) Paul H Sugarbaker   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Cytoreductive Surgery and Intraoperative Hyperthermic Intraperitoneal Chemotherapy with Paclitaxel: A Clinical and Pharmacokinetic Study

(2008) Eelco de Bree et al.   ANNALS OF SURGICAL ONCOLOGY

8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer

(2008) Vic J. Verwaal et al.   ANNALS OF SURGICAL ONCOLOGY

Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy

(2008) Santiago González-Moreno et al.   JOURNAL OF SURGICAL ONCOLOGY